GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential
Open accessThe DOI matches its Crossref record; 286 of the 286 references it cites were found in a registry or an index.
Abstract
G protein-coupled estrogen receptor (GPER) significantly influences metabolic regulation by engaging multiple signaling pathways that affect overall metabolic health. Its structure and signaling mechanisms drive its diverse roles. Our team and others have successfully demonstrated that GPER modulates nutrient metabolism, spanning glucose, protein, and lipid metabolism, while also contributing to vitamin and mineral metabolism. Studies have linked GPER to metabolic disorders, including type 2 diabetes, nonalcoholic fatty liver disease, metabolic syndrome, and cardiovascular diseases, as well as thyroid disorders, highlighting its wide-reaching metabolic impact. GPER holds promise for energy balance and weight management by regulating energy expenditure and thermogenesis. Moreover, it appears to influence the metabolism of cancer cells during tumor progression. Rapid advancements in GPER agonist and antagonist research have highlighted the therapeutic potential of GPER agonists for treating metabolic diseases. Further investigations into GPER biology, mechanisms, and clinical applications will support novel therapeutic strategies, establishing GPER as a key target in metabolic research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many of the beneficial effects of E2 on energy metabolism are increasingly being attributed to its interaction with GPER1, including its rapid effects on insulin sensitivity, hepatic glucose and lipid metabolism (132, 133).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [133]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The metabolic benefits of E2 have been well studied, with evidence that it promotes insulin-sensitivity and improved lipid metabolism in tandem with estrogen receptors, primarily ERα (90) and GPER1 (133).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–286 of 286
Xu, Q., Zhou, L., Ri, H., Li, X., Zhang, X., Qi, W., & Ye, L. (2022) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2022.104007 · Cited by 14 · cited 2×
“Research highlights the critical role of GPER in thyroid physiology, influencing thyroid cell proliferation and differentiation, and thyroid hormone synthesis [204, 205].”
Self-citationRegulation of human endothelial cell migration by oral contraceptive estrogen receptor ligands
Dama, A., Baggio, C., Trevisi, L., Bolego, C., & Cignarella, A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175591 · Cited by 14 · cited 1×
“GPER agonists exert protective effects on endothelial cells by promoting proliferation and migration to facilitate vascular repair, suggesting that GPER has potential protective effects on the cardio-vascular health of elderly women [196].”
Liu, Y., Wang, H., Liang, Y., Guo, Z., Qu, L., Wang, Y., Zhang, C., Sun, G., & Li, Y. (2023) · BMC Public Health · doi:10.1186/s12889-023-16468-z · Cited by 14 · cited 1×
“GPER can significantly increase the uptake of branched-chain amino acids (BCAAs), including leucine, isoleucine, and valine, by tumor cells, thereby promoting their anabolic metabolism [245, 246].”
Kim, N., Kwon, J., Shin, U. S., & Jung, J. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.072 · Cited by 14 · cited 1×
“Furthermore, GPER can affect the redox state within cells, influencing their oxygen utilization and thereby enhancing tumor cell adaptability in hypoxic environments [231].”
Bello, M., Méndez-Luna, D., Sarmiento, V., Correa‐Basurto, J., Nájera, N., Villarreal, F. J., & Ceballos, G. M. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.006 · Cited by 13 · cited 3×
“Its amino acid composition dictates ligand selectivity and affinity, with specific residues critical for estrogen recognition [17].”
Shao, X., Li, J., Xu, F., Chen, D., & Liu, K. (2020) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2020/8811477 · Cited by 13 · cited 1×
“…bowel disease (IBD) exhibit downregulated GPER expression in intestinal tissue, accompanied by elevated proinflammatory cytokine levels, whereas female patients are more likely to benefit from GPER agonists, which increase anti-inflammatory signaling and reduce intestinal inflammation [76].”
Self-citationKhan, S. U., Ahemad, N., Chuah, L., Naidu, R., & Htar, T. T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1830853 · Cited by 13 · cited 2×
“PKA also influences cell growth, proliferation, and survival [23, 32, 33].”
Khan, S. U., Ahemad, N., Chuah, L., Naidu, R., & Htar, T. T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1844059 · Cited by 13 · cited 2×
“Additionally, GPER influences other hormones, including growth hormone and thyroid hormone, and increases adrenaline secretion to increase energy expenditure [14].”
Méndez-Luna, D., Morelos-Garnica, L. A., García-Vázquez, J. B., Bello, M., Martínez, I. I. P., Fragoso-Vázquez, M. J., González, A. D., de Pedro, N., Gómez-Vidal, J. A., Mendoza-Figueroa, H. L., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14010049 · Cited by 13 · cited 2×
“It also induces autophagy to support cell survival, regulating enzymes such as ACC and HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) to limit adipocyte processes [64, 65].”
Wong, K., Kong, T., Poon, C. C., Yu, W., Zhou, L., & Wong, M. (2023) · Phytotherapy Research · doi:10.1002/ptr.7939 · Cited by 13 · cited 3×
“In osteoblasts lacking ER-α66, the overexpression of GPER and ER-α36 can significantly increase OPG expression, further enhancing bone-protective effects [143].”
Nohara, T., Tsuji, M., Oguchi, T., Momma, Y., Ohashi, H., Nagata, M., Ito, N., Yamamoto, K., Murakami, H., & Kiuchi, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11082135 · Cited by 13 · cited 1×
“Tamoxifen and raloxifene serve as selective agonists of GPER, which is particularly significant in ERα-negative or ERα-resistant tumor cells [257, 268].”
Elmi, M. A., Motamed, N., & Picard, D. (2023) · Cells · doi:10.3390/cells12212571 · Cited by 13
Lv, X., Miao, C., Liu, M., Wang, X., Wang, L., & Wang, D. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22603 · Cited by 12 · cited 1×
“Estrogen, acting via GPER, helps maintain the balance of bone remodeling by promoting osteoblast mineralization and inhibiting osteoclast activity [130].”
Huss, L., Butt, S. T., Borgquist, S., Elebro, K., Sandsveden, M., Manjer, J., & Rosendahl, A. H. (2022) · Nutrients · doi:10.3390/nu14163353 · Cited by 12 · cited 1×
“As a nuclear receptor, VDR binds to the active metabolite 1,25-dihydroxyvitamin D3 to regulate gene expression, thereby governing calcium absorption and maintaining bone health [104, 105].”
Léopold, V., Chouchane, O., Butler, J. M., Schuurman, A. R., Michels, E. H. A., de Brabander, J., Schomakers, B. V., van Weeghel, M., Picavet, D. I., Grootemaat, A. E., et al. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.102213 · Cited by 12 · cited 1×
“For example, GPER promotes the phosphorylation of AMPK, enhancing cellular adaptation to energy deficits and improving metabolic efficiency [170, 221, 222].”
Advances in immune regulation of the G protein-coupled estrogen receptor
Dong, H., Zeng, X., Xu, J., He, C., Sun, Z., Liu, L., Huang, Y., Sun, Z., Cao, Y., Peng, Z., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112369 · Cited by 12 · cited 1×
“Research has shown that GPER promotes the biosynthesis of fatty acids by regulating the expression of genes associated with fatty acid synthesis [175, 238, 239], providing essential lipid components for tumor cells [238].”
Self-citationMembrane-initiated estradiol signaling regulates the central nervous system
Micevych, P. E. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.10.002 · Cited by 11 · cited 1×
“Specifically, GPER upregulates antioxidant enzyme expression via downstream signaling, reducing oxidative stress-induced damage to retinal cells [116].”
Wang, H., Sun, X., Chou, J.-H., Lin, M., Ferrario, C. M., Zapata‐Sudo, G., & Groban, L. (2016) · Data in Brief · doi:10.1016/j.dib.2016.11.057 · Cited by 11 · cited 1×
“For example, the GPER-mediated enhancement of mitochondrial function could improve the efficiency of metabolic pathways reliant on B vitamins as coenzymes [129].”
Li, R., Wang, Y., Chen, P., Meng, J., & Zhang, H. (2020) · Aging · doi:10.18632/aging.103733 · Cited by 11
Jafarynezhad, F., Shahbazian, M., Farhadi, Z., Yadeghari, M., Rezvani, M. E., Safari, F., & Azizian, H. (2022) · Intern J Endocrinol Metab · doi:10.5812/ijem-123560 · Cited by 11 · cited 3×
“This process not only helps to increase the energy supplied to muscles but also enhances exercise endurance and overall metabolic health [96].”
Postiglione, A. E., Adams, L. L., Ekhator, E. S., Odelade, A. E., Patwardhan, S., Chaudhari, M., Pardue, A., Kumari, A., LeFever, W. A., Tornow, O. P., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107817 · Cited by 11 · cited 1×
“GPER activates the MAPK signaling pathway via the Gβγ complex, notably ERK1/2 [46], a key regulator of cellular metabolism [47].”
Lipids Metabolism and Cardiometabolic Diseases
Gaggini, M., & Vassalle, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417460 · Cited by 11 · cited 1×
“In recent years, lipid metabolism has emerged as a critical focus in the prevention and treatment of metabolic diseases [88].”
Muhammad, A. I., Hixon, J. C., Yusuf, A. P., Zarete, J. I. R., Johnson, I., Miller, J., Adu-Addai, B., Yates, C. C., & Mahavadi, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-54213-7 · Cited by 11 · cited 4×
“It binds the Gs alpha subunit (Gαs) and Gs alpha q (Gαq) subunits, activating adenylyl cyclase (AC) and phospholipase C to release calcium ions and elicit other responses [20–22].”
InfluentialGPER1 in the thyroid: A systematic review
Manfroi, P. D. A., Bertoni, A. P. S., & Furlanetto, T. W. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117112 · Cited by 10 · cited 2×
“Research highlights the critical role of GPER in thyroid physiology, influencing thyroid cell proliferation and differentiation, and thyroid hormone synthesis [204, 205].”
Epigenetic and environmental regulation of adipocyte function
Matsumura, Y., Osborne, T. F., & Sakai, J. (2022) · The Journal of Biochemistry · doi:10.1093/jb/mvac033 · Cited by 10
Ma, J., Hu, J., Wang, X., Zhang, S., Li, Z., & Liu, J. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10315-z · Cited by 10 · cited 1×
“GPER contributes to cardiovascular protection by suppressing oxidative stress and enhancing endothelial function [190].”
Self-citationZhang, Y., Jiang, T., Ni, S., Liu, W., Luo, P., Hao, S., Wang, P., & Guo, L. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2022.68.6.20 · Cited by 10
Regulation of cardiac function by cAMP nanodomains
Folkmanaite, M., & Zaccolo, M. (2023) · Bioscience Reports · doi:10.1042/bsr20220953 · Cited by 10
Abdel‐Hameed, R., Ahmed, E. K., Mahmoud, A. A., & Atef, A. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121860 · Cited by 10
Lee, I., Doepner, M., Weissenrieder, J., Majer, A. D., Mercado, S., Estell, A., Natale, C. A., Sung, P. J., Foskett, J. K., Carroll, M. P., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0478 · Cited by 10 · cited 1×
“They can effectively activate GPER without affecting other estrogen receptors (including ERα and ERβ) [250].”
GPER involvement in inflammatory pain
Jouffre, B., Acramel, A., Jacquot, Y., Daulhac, L., & Mallet, C. (2023) · Steroids · doi:10.1016/j.steroids.2023.109311 · Cited by 10 · cited 2×
“Similarly, inflammatory factors can alter the metabolic characteristics of tumor cells and promote their malignant transformation [234].”
Arisawa, K., Matsuoka, A., Ozawa, N., Ishikawa, T., Ichi, I., & Fujiwara, Y. (2023) · Nutrients · doi:10.3390/nu16010038 · Cited by 10
Pinheiro, L. V., Costa‐Pinheiro, P., & Wellen, K. E. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041544 · Cited by 10 · cited 1×
“This activated pathway stimulates phospholipase C (PLC) to hydrolyze PIP2 into DAG and IP3 [40].”
Ding, F., Zheng, P., Yan, X., Chen, H.-J., Fang, H., Luo, Y., Peng, Y., Zhang, L., & Yan, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135376 · Cited by 10
Natale, C. A., Mercado, S., Zhuang, R., Aguirre‐Portolés, C., Olayide, I., Arnatt, C. K., Seykora, J. T., Garyantes, T. K., Luke, W., & Ridky, T. W. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0632 · Cited by 10
Perri, M., Aiello, F., Cione, E., Carullo, G., Amendola, L., Mazzotta, S., & Caroleo, M. C. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00012 · Cited by 9 · cited 1×
“In addition, researchers are exploring GPER antagonists based on molecular design [284, 285]; these compounds have shown good biocompatibility and pharmacokinetic properties in both in vivo and in vitro experiments [286], suggesting their potential applications in metabolic diseases in the future…”
Wang, Y., Wu, J., & Shi, A. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220408123746 · Cited by 9
Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
Tappia, P. S., & Dhalla, N. S. (2022) · Cells · doi:10.3390/cells11162488 · Cited by 9 · cited 1×
“IP3, a key second messenger, binds endoplasmic reticulum receptors to rapidly mobilize calcium, modulating excitability and metabolism [41–43].”
Peixoto, P., Vieira-Alves, I., Couto, G. K., Lemos, V. S., Rossoni, L. V., Bissoli, N. S., & dos Santos, R. L. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120917 · Cited by 9 · cited 1×
“GPER mitigates endothelial damage by regulating calcium signaling, the PI3K/AKT pathway, and the MAPK pathway, thereby bolstering antioxidant and anti-inflammatory capacities [192].”
Orlicky, D. J., Smith, E. E., Bok, R., Guess, M. K., Rascoff, L. G., Arruda, J. S., Hutchinson-Colas, J. A., Johnson, J., & Connell, K. A. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01283-z · Cited by 9 · cited 1×
“In animal models, GPER activation ameliorates endothelial dysfunction linked to hypertension and atherosclerosis, underscoring its potential in CVD prevention and treatment [195].”
Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
Behrooz, L., Lenneman, C. G., & Hamburg, N. M. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01961-z · Cited by 9 · cited 1×
“Epidemiological data reveal distinct sex differences in CVD incidence and mortality, with rates notably increasing in women following menopause [187–189].”
Liu, X., Cheng, Z., Shang, X., Zhang, H., Liu, X., Pan, W., Fu, J., Xue, Q., & Zhang, A. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c01602 · Cited by 9
ERK1/2 interaction with DHPS regulates eIF5A deoxyhypusination independently of ERK kinase activity
Becker, A. E., Kochanowski, P., Wu, P., Wątor, E., Chen, W., Guchhait, K., Biela, A. P., Grudnik, P., & Park, J. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114831 · Cited by 9 · cited 1×
“GPER activates the MAPK signaling pathway via the Gβγ complex, notably ERK1/2 [46], a key regulator of cellular metabolism [47].”
Qi, M., Jin, Y., Si, L., Fu, H., Shi, X., Liu, Y., Wang, Y., & Guo, R. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70129 · Cited by 9 · cited 1×
“Specific pharmacological targeting of GPER offers promising clinical applications [6–8].”
Hypoxia enhances steroidogenic competence of buffalo (Bubalus bubalis) granulosa cells
Zhang, Y., Zhang, J., Sun, J., Ouyang, Y., Shi, D., & Lu, F. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.07.031 · Cited by 8
Whispers of the polycystic ovary syndrome theater: Directing role of long noncoding RNAs
Lin, X., Nie, X., Deng, P., Wang, L., Hu, C., & Jin, N. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.05.003 · Cited by 8 · cited 1×
“PCOS is a common endocrine disorder that affects women’s reproductive health and is often associated with hormonal imbalances [151], ovarian dysfunction and metabolic abnormalities [152, 153].”
The role and mechanism of AMPK in pulmonary hypertension
Hou, J., Nie, Y., Wen, Y., Hua, S., Hou, Y., He, H., & Sun, S. (2024) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666241271990 · Cited by 8 · cited 1×
“For example, GPER activation promotes AMPK phosphorylation, increasing AMPK activity, increasing fatty acid oxidation, and suppressing fatty acid synthesis to regulate cellular metabolism [59].”
Small molecule inhibitors for cancer metabolism: promising prospects to be explored
Liu, D., Wang, H., Li, X., Liu, J., Zhang, Y., & Hu, J. Y. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04501-4 · Cited by 7 · cited 1×
“Some nonselective agonists can positively influence obesity and type 2 diabetes by modulating cellular signaling pathways that affect energy metabolism and fat accumulation [257, 258].”
Self-citationShimura, T., Sunaga, K., Yamazaki, M., Honoka, N., Sasatani, M., Kamiya, K., & Ushiyama, A. (2024) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2295297 · Cited by 7 · cited 1×
“AMPK activation depends on the upstream kinases liver kinase B1 (LKB1) and calcium/calmodulin-dependent protein kinase beta (CaMKKβ) [60], which phosphorylate AMPK under conditions such as oxidative stress, nutrient deprivation, or exercise, influencing metabolism and cell survival [61].”
Awasthi, B. P., Chaudhary, P., Lim, D., Yadav, K., Lee, I., Banskota, S., Chaudhary, C. L., Karmacharya, U., Lee, J., Im, S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02458 · Cited by 7 · cited 3×
“GPER also stimulates the release of anti-inflammatory cytokines, reducing proinflammatory responses to alleviate inflammation [72].”
Chen, S., Xiao, J., Zhou, S., Wumiti, T., Zhao, Z., Zhao, R., Pan, Y., Wang, Q., Ma, Y., Wu, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052027 · Cited by 7 · cited 1×
“Previous studies have shown that GPER activation can upregulate the expression of Runx2 and osteocalcin, both of which are genes related to bone formation [110, 144].”
Liu, J., Patterson, S., Goel, S., Brown, C. A., de Ferranti, S. D., & Gooding, H. C. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.03.008 · Cited by 6 · cited 1×
“CVDs are a leading cause of mortality worldwide, with a particularly significant impact on women [184–186].”
Self-citationWang, D., Wang, M., Sun, P., & Gao, Q. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/133484 · Cited by 6 · cited 1×
“In atherosclerosis, GPER promotes smooth muscle cell proliferation and migration via the PI3K/AKT pathway [197, 198] and reduces oxidative stress by downregulating Nox1 expression, thereby decreasing reactive oxygen species production [199].”
Assessment of Metabolic Regulation by Estrogen Receptors
Sharma, G., & Prossnitz, E. R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1920-9_21 · Cited by 6 · cited 2×
“Accumulating evidence links GPER to metabolic regulation, highlighting its key role in disease-related metabolic processes [4, 5].”
Sanjari, M., Yarmohammadi, H., Fahimfar, N., Hajivalizadeh, F., Hesari, E., Mansourzadeh, M. J., Gorgani, K., Khalagi, K., Hajipour, F., Larijani, B. A., et al. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01257-7 · Cited by 6 · cited 1×
“With accelerated global aging, the incidence of metabolic bone disease (MBD) is increasing annually and has become one of the important challenges facing public health [139].”
Wang, X., Zhou, J., Wang, Y., Li, X., Hu, Q., Luo, L., Liu, X., Liu, W., & Ye, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29428 · Cited by 6 · cited 1×
“In mouse models, GPER activation reduces inflammatory factor secretion and astrocyte activation following optic nerve injury by inhibiting nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) signaling, protecting retinal neurons and alleviating neuroinflammation [71, 72].”
Self-citationSon, S., & Im, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179532 · Cited by 6 · cited 2×
“Additionally, GPER influences macrophage polarization, promoting the proliferation of anti-inflammatory M2 macrophages, which helps suppress obesity-related inflammation [180, 182, 183].”
Yu, X., Nguyen, P., Burns, N. C., Heaps, C. L., Stallone, J. N., Sohrabji, F., & Han, G. (2022) · Steroids · doi:10.1016/j.steroids.2022.108997 · Cited by 5 · cited 2×
“Additionally, GPER attenuates inflammation by modulating inflammatory mediators, thereby slowing the progression of atherosclerosis [200].”
Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway
Zhu, S., Wang, S., & Luo, T. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109689 · Cited by 5 · cited 1×
“In the liver, GPER improves lipid metabolism, thereby reducing fat accumulation within the liver [100].”
Nam, S. W., Hwang, J. W., & Han, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115433 · Cited by 5
Hixon, J. C., Zarete, J. I. R., White, J. A., Hilaire, M., Muhammad, A. I., Yusuf, A. P., Adu-Addai, B., Yates, C. C., & Mahavadi, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105260 · Cited by 5 · cited 1×
“Studies have shown that the expression level of GPER in patients with T2D is closely related to their insulin sensitivity, with the downregulation of GPER expression being directly associated with the occurrence of insulin resistance [137].”
Mohamed Anasdeen, S., Shahinaz, S., & Vijayakumar, T. M. (2024) · Cureus · doi:10.7759/cureus.67151 · Cited by 5
Dräger, O., Gottschalk, J., Wischmeyer, E., & Windmöller, B. A. (2024) · Gene & Protein in Disease · doi:10.36922/gpd.4632 · Cited by 5
Zhang, H., Li, C., Lu, S., Wu, H., Li, J., Liu, Q., Yan, Y., Tang, Y., Xu, R., Zhao, X., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138827 · Cited by 5
Self-citationMachens, A., Lorenz, K., Weber, F., & Dralle, H. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1562-3455 · Cited by 4 · cited 1×
“Epidemiological studies have indicated a marked increase in the thyroid disease incidence in recent decades, particularly among women [202], with thyroid cancer rates showing a persistent increasing trend [203].”
Editorial: GPER and Human Pathologies
Jacquot, Y., Kampa, M., & Lindsey, S. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.794332 · Cited by 4
ERα, but not ERβ and GPER, Mediates Estradiol-Induced Secretion of TSH in Mouse Pituitary
Xiao, Y., & Chen, D. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-03823-w · Cited by 4
Mancinelli, C. D., Marx, D. C., Gonzalez-Hernandez, A. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553551 · Cited by 4 · cited 1×
“Conversely, the intracellular C-terminus mediates interactions with G proteins and effectors [19], driving signaling cascades.”
Assersen, K. B., Jensen, B. L., Enggaard, C., Vanhoutte, P. M., & Hansen, P. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02909-0 · Cited by 4
Unveiling the role of microRNAs in metabolic dysregulation of Gestational Diabetes Mellitus
He, L., Wang, X., & Chen, X. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2024.100924 · Cited by 4 · cited 1×
“In recent years, glucose metabolic homeostasis has been widely recognized as a critical factor in maintaining metabolic health [78].”
Sirizi, M. A. G., Esmailidehaj, M., Mohamadi-Zarch, S.-M., Yadeghari, M., & Azizian, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03438-4 · Cited by 4
da Silva, G. M., de Figueiredo, C. S., Oliveira, A. C. D. R., Raony, Í., Miranda, R. A. D. A., Silva, E. D. M., Guilarducci, C. V. V., dos Santos, A. A., & Giestal‐de‐Araujo, E. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103780 · Cited by 3
Fayyad, N. S., & Al-Rikabi, H. R. (2022) · PubMed Central · doi:10.22092/ari.2022.358736.2294 · Cited by 3 · cited 1×
“Abbreviations: VDR, vitamin D receptor; PPARα, peroxisome proliferator-activated receptor alpha quality of life and health of hundreds of millions of people [135, 136].”
G protein-coupled estrogen receptor expression in postnatal developing mouse retina
Piñon-Teal, W. L., & Ogilvie, J. M. (2024) · Frontiers in Ophthalmology · doi:10.3389/fopht.2024.1331298 · Cited by 3 · cited 2×
“In the retina, GPER activation can promote the survival of retinal neurons and enhance the function of photoreceptors, which is crucial for maintaining a normal visual capacity [114].”
Hanafi, D., Onyenwoke, R. U., & Kimbro, K. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126499 · Cited by 3 · cited 1×
“Additionally, GPER influences mitochondrial function, indirectly affecting fatty acid oxidation, and plays an important role in energy expenditure and fat accumulation [101].”
An In Vivo Study of LNS8801 , a GPER Agonist, in a Spontaneous Melanoma‐Prone Mouse Model, TGS
Marinaro, C., Sauer, J., Natale, C. A., Ridky, T. W., & Chen, S. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13197 · Cited by 3
Radhakrishnan, R., Lor, A., Li, D., Mudaliar, D. J., & Lobo, G. P. (2024) · Journal of Visualized Experiments · doi:10.3791/67036 · Cited by 3 · cited 1×
“The metabolism of vitamin A, including its conversion to its active form, retinol, plays a critical role in retinal function [113].”
Liu, D., Zheng, M., Lu, C., Miao, M., Zhan, Y., Ma, F., Yin, Y., Wei, M., Wang, W., Wang, W., et al. (2024) · Journal of Lipids · doi:10.1155/2024/5513473 · Cited by 3
Self-citationZhong, H., Liu, H., Zhong, W., Wang, L., Luo, J.-M., Chen, Q., Li, R., Zhang, R., Liu, Z., & Cheng, Y. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100556 · Cited by 3 · cited 1×
“GPER activation also promotes mitochondrial biogenesis, improves mitochondrial function, and bolsters cellular energy metabolism [4, 216, 217].”
GPER1 contributes to T3-induced osteogenesis by mediating glycolysis in osteoblast precursors
Xue, Y., Liu, G., Ke, D., Yu, Y., & Hou, J. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231198067 · Cited by 2 · cited 1×
“Additionally, activated GPER may increase glucose and lipid metabolism in osteoblasts, thereby improving the activity and function of bone cells [110, 149, 150].”
Direct in vitro action of estrone on uterine and white adipose tissue in obesity
Valle, M. I., Cutini, P. H., Cepeda, S. B., Campelo, A. E., Sandoval, M. J., & Massheimer, V. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112142 · Cited by 2 · cited 2×
“By downregulating Studies have shown that GPER can increase the expression of fatty acid oxidation-related enzymes, thereby increasing the rate of fatty acid oxidation [99].”
Natale, C. A., Mercado, S., Zhuang, R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.26.625421 · Cited by 2 · cited 4×
“…inflammation is recognized as a key factor in inducing insulin resistance, and GPER can modulate intracellular signaling pathways or suppress the expression of proinflammatory cytokines, which reduces the interference of chronic inflammatory responses and improves insulin resistance [1, 34].”
InfluentialGPER agonist G-1 activates YAP to induce apoptosis in breast cancer cells
Fu, Z., Xin, X., Zhan, Y., Fan, X., Li, X., Chen, T., & Wang, X. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106693 · Cited by 2
Gupta, A., Shinde, P. G., Jorvekar, S. B., Humane, A. S., Chandrasekaran, M., Borkar, R. M., & Selvaraju, S. (2025) · FEBS Letters · doi:10.1002/1873-3468.70030 · Cited by 2 · cited 1×
“GPER can inhibit the activity of the branched-chain α-ketoacid dehydrogenase complex (BCKDH), leading to the accumulation of branched-chain amino acids within cells; this metabolic reprogramming promotes the adaptive growth of tumor cells [247].”
CLINICAL AND ENDOCRINE ALTERATIONS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME.
Kotori, M., Ferizi, L., Kocinaj, A., Ferizi, V., & Kotori, J. (2024) · PubMed · Cited by 1
Suzuki, H., Fujiwara, Y., Ariyani, W., Amano, I., Ishii, S., Ninomiya, A., Sato, S., Takaoka, A., & Koibuchi, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094727 · Cited by 1 · cited 1×
“In addition to its role in adipose tissue, GPER influences mitochondrial biogenesis and energy metabolism [214].”
Research works printed but not linked: 9
- Sirizi MAG, Esmailidehaj M, Mohamadi-Zarch SM, et al. Cardioprotective effects of Gper agonist in ovariectomized diabetic rats: reversing Er stress and structural changes. Naunyn Schmiedebergs Arch Pharmacol. 2024. h t t p s : / / d o i . o r g / 1 0 . 1 0 0 7 / s 0 0 2 1 0 -0 2 4 -0 3 4 3 8 -4. · DOI
- Pepermans RA, Sharma G, Prossnitz ER. G protein-coupled estrogen receptor in cancer and stromal cells: functions and novel therapeutic perspectives. Cells. 2021. https://doi.org/10.3390/cells10030672. · DOI
- Gupta A, Shinde PG, Jorvekar S, et al. G protein-coupled oestrogen receptor regulates branched-chain amino acid metabolism through c-jun n-terminal kinase. FEBS Lett. 2025. https://doi.org/10.1002/1873-3468.70030. · DOI
- Cao Y, Zhao LW, Chen ZX, et al. New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease. Front Neurosci. 2024;18:1430465. https://doi.org/10.3389/fnins.2024.1430465. · DOI · Paper page
- Pawar P, Ma L, Byon CH, et al. Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin. Clin Cancer Res. 2009;15(4):1288–96. https://doi.org/10.1158/1078-0432.Ccr-08-1150. · DOI
- Di Leo A, Jerusalem G, Torres R, et al. First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: a post-hoc analysis of the confirm study. Breast. 2018;38:144–9. https://doi.org/10.1016/j.breast.2017.12.016. · DOI
- Lappano R, Santolla MF, Pupo M, et al. Mibe acts as antagonist ligand of both estrogen receptor α and Gper in breast cancer cells. Breast Cancer Res. 2012;14(1): R12. https://doi.org/10.1186/bcr3096. · DOI · Paper page
- Maggiolini M, Santolla MF, Avino S, et al. Identification of two benzopyrroloxazines acting as selective Gper antagonists in breast cancer cells and cancer-associated fibroblasts. Future Med Chem. 2015;7(4):437–48. https://doi.org/10.4155/fmc.15.3. · DOI
- Lappano R, Rosano C, Pisano A, et al. A calixpyrrole derivative acts as an antagonist to gper, a g-protein coupled receptor: mechanisms and models. Dis Model Mech. 2015;8(10):1237–46. https://doi.org/10.1242/dmm.021071. · DOI
Cited by
Lee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Hao, X., Cao, H., Shi, B., Bai, C., Liu, X., & Meng, X. (2026) · iScience · doi:10.1016/j.isci.2026.114890 · Cited by 6
“55 The potential endocrine disrupting effects of BPB and BPAF elevate the risk of ovarian disease, uterine lesions, and breast cancer.”
Targeting GLP1 receptor for reducing global cardiovascular risk
Curcio, A., Meringolo, F., Marincolo, C., Polimeni, A., & Costanzo, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07736-8 · Cited by 2
“It has been demonstrated that G-protein coupled estrogen receptors increase resistance to oxidative damage [52] and exert anti-inflammatory effects by inhibiting the mitogen activated protein kinase (MAPK) pathways [53] reducing cardiac arrhythmias [54].”
Ormiston, K., Shinde, N., Sarathy, G., Zhang, A., Bauer, M., Shukla, R. K., Alsammerai, S., Gupta, A., Bennouna, D., Wesolowski, J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041951 · Cited by 2
“Activation of GPER by estrogen has shown to regulate tissue metabolism specifically by increasing oxidative phosphorylation, promoting aerobic glycolysis, and reducing adipocyte hypertrophy [23–25].”
Self-citationMore than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer
Molina, L., Torres, R. F., Spies, J., Meneses, S. S., Soto, M., Carrasco, J., Gálvez, J., Muñoz, D., Soto, J., & Arancibia, Y. (2026) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2026.1002377 · Cited by 2
Metadata
- Authors
- Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., Li, J., Zeng, X., Hu, Q., Huang, X., Xu, X., Dong, H., Zhong, J., Huang, Y., Lv, Q., Liu, B., Qiu, Y.-A., & Yu, T.
- Affiliations
- Jiangxi Provincial Cancer Hospital (CN)
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- Nanchang Medical College (CN)
- University of Chicago Medical Center (US)
- The University of Agriculture, Peshawar (PK)
- Corresponding author
- Liu, Bo
- Yu, Tenghua
- ORCID
- Venue
- Journal of Translational Medicine
- Published
- 2025-08-26
- Volume
- 23
- Issue
- 1
- Pages
- 960-960
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC12382220
- OpenAlex
- W4413658314
- Cited by
- 13
- References
- 284
- Citations by year
- 2026: 12 · 2025: 1
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82160565, 82260565)
- Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province (20232BCJ23035)
- Education Department of Jiangxi Province (GJJ2203532)
- General Project of Jiangxi Provincial Administration of Traditional Chinese Medicine (2023B1281)
- Open Research Fund of Jiangxi Cancer Hospital & Institute (2021J16)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- G protein-coupled estrogen receptor, metabolic homeostasis, nutrient metabolism, glucose metabolism, lipid metabolism, protein metabolism, type 2 diabetes, non-alcoholic fatty liver disease, metabolic syndrome, cardiovascular disease, thyroid dysfunction, energy balance, thermogenesis, cancer metabolism, metabolic disease treatment
- MeSH terms
- Animals, Energy Metabolism, Homeostasis, Humans, Metabolic Diseases, Receptors, Estrogen, Signal Transduction, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.